SCM
DXCM icon

Steadfast Capital Management’s DexCom DXCM Stock Holding History

Steadfast Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,000
Closed -$4.88M – 51
2023
Q2 		$4.88M Buy
+38,000
New +$4.6M 0.13% 49
2022
Q2 		– Sell
-797,480
Closed -$102M – 51
2022
Q1 		$102M Buy
+797,480
New +$87.2M 1.75% 16

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Steadfast Capital Management's DXCM Position: Q3 2023 in Review

Steadfast Capital Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 38,000 shares — an estimated $4.88M sold.

Steadfast Capital Management first reported a position in DXCM in Q1 2022 and held it in 2 quarters. The position peaked at $102M in Q1 2022. 904 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Steadfast Capital Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Steadfast Capital Management sold 38,000 DexCom shares in Q3 2023, an estimated $4.88M.
  • Steadfast Capital Management first reported a position in DexCom in Q1 2022 and held it in 2 quarters.
  • Steadfast Capital Management's DexCom position peaked at $102M in Q1 2022.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Steadfast Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.